Back to Authors

Imam, J. Saadi

https://orcid.org/0000-0003-3463-838X

Mayo Clinic

The University of Texas Medical Branch at Galveston

Citations 4

Transbronchial Forceps Biopsy in the Intensive Care Unit
Burnside, Rebecca, Fernández-Bussy, Sebastián , Brigham, Tara , Patel, Neal M. , Brigham, Tara J, Brigham, T J , Helgeson, Scott A. , Imam, J. Saadi

Journal of Bronchology & Interventional Pulmonology | March 24, 2021 | Volume: 28 | Issue: 4 | Pages: 281-289

10.1097/lbr.0000000000000767 Get It

Background: A transbronchial forceps lung biopsy performed in mechanically ventilated patients with respiratory failure of unknown etiology has significant uncertainty of diagnostic yield and safety along with sparse literature. This study investigated the complication rate of transbronchial biopsies in mechanically ventilated patients in the intensive care unit and its ability to obtain a diagnosis and change current therapy. Methods: PubMed, Ovid MEDLINE, and Ovid Cochrane Central Register of Controlled Trials databases were systematically searched for all publications of transbronchial lung biopsies in mechanically ventilated patients. We pooled the results of individual studies using random-effects meta-analysis models to achieve the summary proportions. Results: Of the identified 9 observational studies with a total of 232 patients undergoing a transbronchial biopsy, complications occurred in 67 patients [25.2%; 95% confidence interval (CI), 11.5%-42.0%; I 2=70.0%]. Pneumothorax occurred in 24 patients (9.5%; 95% CI, 4.5%-16.2%; I 2=15.9%) and bleeding in 18 patients (8.9%; 95% CI, 4.1%-15.3%; I 2=0%). A diagnosis was given in 146 patients (62.9%; 95% CI, 56.0%-69.1%; I 2=74.6%), with 103 of 210 patients (49.0%; 95% CI, 44.6%-55.1%; I 2=74.9%) having a change in treatment. Conclusion: The results of this meta-analysis suggest that a transbronchial forceps biopsy when performed in mechanically ventilated patients with respiratory failure of unclear etiology had a moderate complication rate. These biopsies resulted in varied diagnoses with a high rate of management change. Randomized controlled trials are necessary to identify the ideal patients to perform a transbronchial forceps biopsy on in the intensive care unit.
Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension
Helgeson, Scott A. , Imam, J. Saadi , Moss, John E. , Hodge, David O. , Burger, Charles D. , Helgeson, Scott A , Burger, Charles

Diseases | May 3, 2018 | Volume: 6 | Issue: 2 | Pages: 33

10.3390/diseases6020033 Get It

Pulmonary arterial hypertension (PAH) is a progressive disease that requires validated biomarkers of disease severity. While PAH is defined hemodynamically by right heart catheterization (RHC), brain natriuretic peptide (BNP) is recommended by guidelines to assess disease status. Retrospectively collected data in 138 group 1 PAH patients were examined for the correlation of BNP levels to simultaneously obtained right heart catheterization (RHC). Patients were mostly Caucasian women, with functional class III symptoms, mean BNP of 406 ± 443 pg/mL, and an average right atrial pressure (RAP) of 9.9 ± 5.7 mm Hg and mean pulmonary artery pressure (mPAP) of 47.3 ± 14.7 mm Hg. Significant correlation was demonstrated between BNP and RAP (p = 0.021) and mPAP (p = 0.003). Additional correlation was seen with right heart size on echocardiography: right atrial (RAE; p = 0.04) and right ventricular enlargement (p = 0.03). An increased BNP level was an independent predictor of mortality (p < 0.0001), along with RAP (p = 0.039) and RAE (p = 0.018). Simultaneous collection of BNP at the time of RHC confirmed the correlation of BNP with right heart hemodynamics. The current results reinforce the use of BNP level as a continuous variable to assess disease severity in group 1 PAH.
Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta‐analysis
Sacco, Keith , Bates, Alexander , Brigham, Tara , Imam, J. Saadi , Burton, M. Caroline , Sacco, Keith A , Brigham, T J , Bates, A.

Allergy | March 29, 2017 | Volume: 72 | Issue: 9 | Pages: 1288-1296

10.1111/all.13168 Get It

Abstract Background A documented penicillin allergy is associated with increased morbidity including length of hospital stay and an increased incidence of resistant infections attributed to use of broader‐spectrum antibiotics. The aim of the systematic review was to identify whether inpatient penicillin allergy testing affected clinical outcomes during hospitalization. Methods We performed an electronic search of Ovid MEDLINE /PubMed, Embase, Web of Science, Scopus, and the Cochrane Library over the past 20 years. Inpatients having a documented penicillin allergy that underwent penicillin allergy testing were included. Results Twenty‐four studies met eligibility criteria. Study sample size was between 24 and 252 patients in exclusively inpatient cohorts. Penicillin skin testing ( PST ) with or without oral amoxicillin challenge was the main intervention described (18 studies). The population‐weighted mean for a negative PST was 95.1% [ CI 93.8‐96.1]. Inpatient penicillin allergy testing led to a change in antibiotic selection that was greater in the intensive care unit (77.97% [ CI 72.0‐83.1] vs 54.73% [ CI 51.2‐58.2], P <.01). An increased prescription of penicillin (range 9.9%‐49%) and cephalosporin (range 10.7%‐48%) antibiotics was reported. Vancomycin and fluoroquinolone use was decreased. Inpatient penicillin allergy testing was associated with decreased healthcare cost in four studies. Conclusions Inpatient penicillin allergy testing is safe and effective in ruling out penicillin allergy. The rate of negative tests is comparable to outpatient and perioperative data. Patients with a documented penicillin allergy who require penicillin should be tested during hospitalization given its benefit for individual patient outcomes and antibiotic stewardship.
Reducing unnecessary testing: an intervention to improve resident ordering practices
Melendez-Rosado, José , Thompson, Kristine M., Cowdell, Jed C. , Sánchez-Álvarez, Catalina , Ung, Ryan, Villanueva, Armando, Jeffers, Kayin , Imam, J. Saadi , Mitkov, Mario V., Kaleem, Tasneem , Jacob, Lewis, Dawson, Nancy L. , Ung, Ryan L, Jeffers, Kayin B, Imam, Jaafer S, Kaleem, Tasneem A, Sanchez-Alvarez, Catalina

Postgraduate Medical Journal | January 20, 2017 | Volume: 93 | Issue: 1102 | Pages: 476-479

10.1136/postgradmedj-2016-134513 Get It

ABSTRACTPurpose of the studyTo reduce the number of unnecessary laboratory tests ordered through a measurement of effects of education and cost awareness on laboratory ordering behaviour by internal medicine residents for common tests, including complete blood cell count (CBC) and renal profile (RP), and to evaluate effects of cost awareness on hospitalisation, 30-day readmission rate and mortality rate.Study design567 patients admitted during February, March and April 2014 were reviewed as the control group. Total CBC, CBC with differential and RP tests were counted, along with readmission and mortality rates. Interventions were education and visual cost reminders. The same tests were reassessed for 629 patients treated during 12 months after intervention in 2015.ResultsData showed a significant increase in CBCs ordered after the intervention (mean number per hospitalisation changed from 1.7 to 2.3 (p&lt;0.001)), a decrease in CBCs with differential (mean number changed from 1.7 to 1.2 (p&lt;0.001)) and no change in RPs ordered (mean number, 3.7 both before and after intervention (p=0.23)). No change was found in mortality rate, but the decrease in the readmission rate was significant (p=0.008).ConclusionsEducation in the form of cost reminders did not significantly reduce the overall ordering of the most common daily laboratory testing in our academic teaching service. We believe further research is needed to fully evaluate the effectiveness of other education forms on the redundant ordering of tests in the hospital setting.